JP2023539847A5 - - Google Patents
Info
- Publication number
- JP2023539847A5 JP2023539847A5 JP2023512721A JP2023512721A JP2023539847A5 JP 2023539847 A5 JP2023539847 A5 JP 2023539847A5 JP 2023512721 A JP2023512721 A JP 2023512721A JP 2023512721 A JP2023512721 A JP 2023512721A JP 2023539847 A5 JP2023539847 A5 JP 2023539847A5
- Authority
- JP
- Japan
- Prior art keywords
- fenretinide
- analog
- pharmaceutically acceptable
- acceptable salt
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063069881P | 2020-08-25 | 2020-08-25 | |
| US63/069,881 | 2020-08-25 | ||
| PCT/CA2021/051148 WO2022040782A1 (en) | 2020-08-25 | 2021-08-19 | Use of fenretinide or an analogue thereof to treat pulmonary fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023539847A JP2023539847A (ja) | 2023-09-20 |
| JP2023539847A5 true JP2023539847A5 (https=) | 2024-07-01 |
Family
ID=80352354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512721A Pending JP2023539847A (ja) | 2020-08-25 | 2021-08-19 | 肺線維症を治療するためのフェンレチニド又はその類似体の使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230310352A1 (https=) |
| EP (1) | EP4203931A4 (https=) |
| JP (1) | JP2023539847A (https=) |
| KR (1) | KR20230079054A (https=) |
| CN (1) | CN116437904A (https=) |
| AU (1) | AU2021329999A1 (https=) |
| BR (1) | BR112023003481A2 (https=) |
| CA (1) | CA3128648A1 (https=) |
| MX (1) | MX2023002347A (https=) |
| WO (1) | WO2022040782A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250142485A (ko) | 2024-03-22 | 2025-09-30 | 경희대학교 산학협력단 | 폐섬유증 예방 또는 치료용 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011127164A2 (en) * | 2010-04-08 | 2011-10-13 | Fate Therapeutics, Inc. | Pharmaceutical compositions to treat fibrosis |
| TWI658830B (zh) * | 2011-06-08 | 2019-05-11 | 日東電工股份有限公司 | Ｈｓｐ47表現調控強化用類視色素脂質體 |
| US10406127B2 (en) * | 2014-07-25 | 2019-09-10 | Laurent Pharmaceuticals | Solid oral formulation of fenretinide |
-
2021
- 2021-08-19 JP JP2023512721A patent/JP2023539847A/ja active Pending
- 2021-08-19 KR KR1020237010037A patent/KR20230079054A/ko active Pending
- 2021-08-19 EP EP21859444.8A patent/EP4203931A4/en not_active Withdrawn
- 2021-08-19 AU AU2021329999A patent/AU2021329999A1/en not_active Abandoned
- 2021-08-19 US US18/022,611 patent/US20230310352A1/en active Pending
- 2021-08-19 WO PCT/CA2021/051148 patent/WO2022040782A1/en not_active Ceased
- 2021-08-19 MX MX2023002347A patent/MX2023002347A/es unknown
- 2021-08-19 CA CA3128648A patent/CA3128648A1/en active Pending
- 2021-08-19 CN CN202180072942.9A patent/CN116437904A/zh active Pending
- 2021-08-19 BR BR112023003481A patent/BR112023003481A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522010A5 (https=) | ||
| JP2024515446A5 (https=) | ||
| US20220387455A1 (en) | Treatment of moderate to severe influenza | |
| US20060134008A1 (en) | Compositions and methods for pulmonary conditions | |
| Sinha et al. | Aerosolized L-epinephrine vs budesonide for post-extubation stridor: A randomized controlled trial | |
| JP2023523557A5 (https=) | ||
| KR20100021451A (ko) | 옥시부티닌 투여를 위한 방법 및 조성물 | |
| JP2023539847A5 (https=) | ||
| CN103957707A (zh) | 与女性胃轻瘫有关的症状的治疗 | |
| RU2018143564A (ru) | Карбоновая кислота, предназначенная для лечения/предупреждения заложенности носа | |
| FI4199922T3 (fi) | (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa | |
| JP2023520929A5 (https=) | ||
| JP2022504435A5 (https=) | ||
| US11304947B2 (en) | Compositions and methods for treating lung injuries associated with SARS-COV-2 infections | |
| JP2010523662A5 (https=) | ||
| JP2009508965A (ja) | 正常な呼吸リズムを回復するための組み合わせｓ−ニトロソチオールをベースとする製薬学的製品 | |
| US20020198228A1 (en) | Composition and method for the treatment of respiratory desease | |
| JP2024501919A5 (https=) | ||
| JP2021176903A (ja) | イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの応用 | |
| JP6188784B2 (ja) | 炎症性および免疫性疾患の治療のための組成物 | |
| US10966988B2 (en) | Method for smoking cessation | |
| Lee et al. | Anti-fibrotic potential of a novel long-acting Glucagon/GIP/GLP-1 triple agonist (HM15211) in preclinical models of idiopathic pulmonary fibrosis | |
| Robuschi et al. | Prevention of fog-induced bronchospasm by high doses of ipratropium bromide in asthmatics | |
| WO2024192149A3 (en) | Method of treating enterovirus in chronic obstructive pulmonary disease patients | |
| JP2024516712A5 (https=) |